AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Wellgistics shares surge 18.18% premarket after securing exclusive smart contract tech license for PharmacyChain and EinsteinRx platforms.
ByAinvest
Wednesday, Nov 26, 2025 4:22 am ET1min read
Wellgistics Health (WGRX) surged 18.18% in premarket trading following the announcement of an exclusive licensing agreement with DataVault AI (DVLT) to integrate digital-ledger smart-contract patents into its PharmacyChain and EinsteinRx platforms. The deal enables Wellgistics to digitize prescription drug tracking using Web 3.0 technology, targeting a $634 billion industry by enhancing transparency, reducing administrative costs, and streamlining rebate processes. Both companies emphasized the strategic value of the partnership, with DataVault CEO Nathaniel Bradley calling it a "revolution" and Wellgistics' interim CEO Prashant Patel aiming to position the firm as a leader in smart contract-enabled pharmaceutical distribution. The move addresses systemic inefficiencies in drug distribution and aligns with broader industry trends toward blockchain-driven solutions.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet